Document:

Waiver and Amendment No.8

 Exhibit 10(xiv) 
  
 EXECUTION COPY 
  
 WAIVER AND AMENDMENT NO. 8 
  
 Dated as of March 16, 2005 
  
 To the banks, financial institutions 
 and other institutional
lenders 
 (collectively, the “Lenders”) 
 parties to the Credit Agreement 
 referred to below and to Merrill Lynch Capital, 
 a division of Merrill Lynch Business Financial 
 Services Inc., as Administrative Agent 
 (in such capacity, the “Administrative Agent”) for the Lenders 

 
 Ladies and Gentlemen: 
  
 We refer to the Credit Agreement, dated as of November 26, 2002, among NDCHealth Corporation, a Delaware corporation (the
“Borrower”), the Lenders and agents from time to time party thereto, Merrill Lynch Capital, a division of Merrill Lynch Business Financial Services Inc., as Administrative Agent and Swing Line Lender, Credit Suisse First Boston, as
Syndication Agent, Bank of America, N.A., as Documentation Agent, and LaSalle Bank National Association, as L/C Issuer, as amended by Letter Amendment and Waiver No. 1, dated as of May 27, 2003, Letter Amendment No. 2 dated as of August 29, 2003,
Amendment No. 3 dated as of December 19, 2003, Letter Amendment No. 4 dated as of January 22, 2004, Letter Amendment No. 5 dated as of August 20, 2004, Letter Amendment No. 6, dated as of November 22, 2004 and Consent and Amendment No. 7, dated as
of February 23, 2005 (as so amended or otherwise modified in writing, the “Credit Agreement”; the terms defined therein being used herein as therein defined). 
  
 The Borrower is restating its financial statements (the “Restated Financial Statements”) with respect to
(a) the Physicians Software business and the information management business for the period from the first quarter of Fiscal Year 2002 through the first quarter of Fiscal Year 2005 (the “Restatement Period”) and (b) such other audit
adjustments for the Restatement Period previously identified to the Lenders, in accordance with GAAP (the “Restatement”), all of which has resulted in a delay in the Borrower’s ability to report its financial results in its
quarterly report for the second fiscal quarter of the Borrower’s Fiscal Year 2005 (the “Q2 Report”). 
  
 The Borrower has delivered a notice to the Administrative Agent and the Lenders stating that Regions Bank, as the trustee (the “Trustee”)
under the Indenture dated as of November 26, 2002 by and among the Trustee, the Borrower, NDC Health Information Services (Arizona) Inc., The Computer Place, Inc., NDC Health Intellectual Property Corp., HISIP Corp., NDCIP, Inc., NDCHealth
Licensing, Inc., TechRX Incorporated, NDC of Canada, Inc. and NDC Acquisition Corp. with respect to the Senior Subordinated Notes (the “Indenture”), has notified the Borrower that it is in Default (as defined in the Indenture) under
Section 501(4) of the 
  
 NDCHealth Corporation – Waiver and
Amendment 

 Indenture as a result of the Borrower’s failure to deliver the Q2 Report within the required time period set forth
in the Indenture (the “Cross Default”). 
  
 SECTION 1. Limited Waivers. We hereby request, and by your execution hereof, you agree to waive the following: 
  
 (a) the Event of Default, pursuant to Section 8.01(b) of the Credit Agreement, resulting from the failure by the Borrower to
deliver (i) financial statements and an officer’s certificate, in accordance with Section 6.01(b) of the Credit Agreement, for the quarter ended November 26, 2004 and (ii) the related Compliance Certificate, in accordance with Section
6.02(b) of the Credit Agreement, 
  
 (b) the
Event of Default, pursuant to Section 8.01(d) of the Credit Agreement, resulting from the misrepresentations under Sections 5.05(b) and (c) and Section 5.15 of the Credit Agreement with respect to the Restated Financial
Statements solely to the extent that they are the subject of the Restatement, and 
  
 (c) the Default or Event of Default, pursuant to Section 8.01(e) of the Credit Agreement, resulting from the Cross Default,

  
 provided, that if the following requirements (the “Waiver
Requirements”) are not met, the waivers set forth in Section 1 of this Waiver will immediately thereupon terminate (such date of termination being the “Waiver Termination Date”) and the Administrative Agent and the Lenders
shall have all of the rights and remedies afforded to them under the Credit Agreement with respect to any such Defaults and Events of Default as though no waiver had been granted by them hereunder: 
  
 (i) the Restated Financial Statements and the Q2 Report are
filed with the SEC and delivered to the Administrative Agent prior to 12:00 noon eastern standard time on March 21, 2005; the annual audited financial statements for Fiscal Years 2002, 2003 and 2004 that constitute part of the Restated Financial
Statements (the “Annual Audited Statements”) shall include a report of independent registered public accounting firm from Ernst & Young LLP, providing that such Annual Audited Statements were prepared in accordance with
generally accepted auditing standards and are not subject to any “going concern” or like qualification or exception or any qualification or exception as to the scope of such audit, and stating that the Annual Audited Statements present
fairly in all material respects the financial condition and results of operations of the Borrower and its Subsidiaries on a consolidated basis in accordance with GAAP; and 
  
 (ii) the financial statements for the quarter ended on November 26, 2004 required pursuant to Section
6.01(b), the officer’s certificate, and Compliance Certificates for such quarter and each quarter covered by the Restated Financial Statements (demonstrating compliance, on a pro forma basis, with all financial covenants as amended to date)
are delivered to the Administrative Agent prior to 12:00 noon eastern standard time on March 21, 2005; and 
  
 NDCHealth Corporation – Waiver and Amendment 
  

 2 

 (iii) the Restatement requires adjustments only to the Restated Financial Statements for
the Restatement Period, as confirmed by a certificate from the Borrower to the Administrative Agent reasonably satisfactory to the Administrative Agent; and 
  
 (iv) the aggregate impact of the Restatement on EBITDA during the Restatement Period and the impact of the Restatement on EBITDA for any
individual fiscal quarter during the Restatement Period does not exceed the amount outlined in a letter from the Borrower to the Administrative Agent, dated March 11, 2005, as confirmed by a certificate from the Borrower to the Administrative Agent
reasonably satisfactory to the Administrative Agent; and 
  
 (v) the Administrative Agent shall have received, prior to 12:00 noon eastern standard time on March 21, 2005, a copy of a fully executed waiver of the default under Section 501(4) of the Indenture from the holders or
duly authorized representatives of such holders representing at least 51% of the Senior Subordinated Notes (that is in full force and effect as of such time and not subject to any conditions to effectiveness that will not be satisfied simultaneously
with the effectiveness of this Waiver and Amendment), and neither the Trustee nor any of the holders of the Senior Subordinated Notes shall have taken any other actions to enforce their rights or remedies under the Senior Subordinated Note Documents
with respect to such default. 
  
 SECTION 2. Amendments.
Subject to the occurrence and continuance of the Effective Date, the Credit Agreement is hereby amended as follows: 
  
 (a) Section 1.01 of the Credit Agreement is hereby amended to add the following definitions in alphabetical order: 
  
 “Amendment No. 8 Effective Date” means
March 16, 2005. 
  
 “Annual Audited
Statements” means the annual audited financial statements for Fiscal Years 2002, 2003 and 2004 that constitute part of the Restated Financial Statements. 
  
 “Restated Financial Statements” means the Borrower’s consolidated financial statements
as adjusted with respect to the Physicians Software business and the information management business and such other audit adjustments identified to the Lenders prior to the Amendment No. 8 Effective Date for the period from the first quarter of
Fiscal Year 2002 through the first quarter of Fiscal Year 2005, all in conformity with the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended. 
  
 “Restatement” means the restatement by the Borrower of the Restated Financial Statements
and such other audit adjustments for the Restatement Period identified to the Lenders prior to the Amendment No. 8 Effective Date, in accordance with GAAP. 
  
 NDCHealth Corporation – Waiver and Amendment 
  

 3 

 “Restatement Conditions” means: 
  
 (a) the Restated Financial Statements and the Q2 Report are
filed with the SEC and delivered to the Administrative Agent prior to 12:00 noon eastern standard time on March 21, 2005; the Annual Audited Statements shall include a report of independent registered public accounting firm from Ernst & Young
LLP, providing that such Annual Audited Statements were prepared in accordance with generally accepted auditing standards and are not subject to any “going concern” or like qualification or exception or any qualification or exception as to
the scope of such audit, and stating that the Annual Audited Statements present fairly in all material respects the financial condition and results of operations of the Borrower and its Subsidiaries on a consolidated basis in accordance with GAAP;
and 
  
 (b) the financial statements for the
quarter ended on November 26, 2004 required pursuant to Section 6.01(b), the officer’s certificate, and Compliance Certificates for such quarter and each quarter covered by the Restated Financial Statements (demonstrating compliance, on
a pro forma basis, with all financial covenants as amended to date) are delivered to the Administrative Agent prior to 12:00 noon eastern standard time on March 21, 2005; and 
  
 (c) the Restatement requires adjustments only to the Restated Financial Statements for the Restatement
Period, as confirmed by a certificate from the Borrower to the Administrative Agent reasonably satisfactory to the Administrative Agent; and 
  
 (d) the aggregate impact of the Restatement on EBITDA during the Restatement Period and the impact of the Restatement on EBITDA for any
individual fiscal quarter during the Restatement Period does not exceed the amount outlined in a letter from the Borrower to the Administrative Agent, dated March 11, 2005, as confirmed by a certificate from the Borrower to the Administrative Agent
reasonably satisfactory to the Administrative Agent; and 
  
 (e) the Administrative Agent shall have received, prior to 12:00 noon eastern standard time on March 21, 2005, a copy of a fully executed waiver of the default under Section 501(4) of the Indenture from the holders or
duly authorized representatives of such holders representing at least 51% of the Senior Subordinated Notes (that is in full force and effect as of such time and not subject to any conditions to effectiveness that will not be satisfied simultaneously
with the effectiveness of this Waiver and Amendment), neither the Trustee nor any of the holders of the Senior Subordinated Notes shall have taken any other actions to enforce their rights or remedies under the Senior Subordinated Note Documents
with respect to such default. 
  
 “Restatement Period” means the period from the first quarter of Fiscal Year 2002 through the first quarter of Fiscal Year 2005. 
  
 NDCHealth Corporation – Waiver and Amendment 
  

 4 

 (b) Section 2.01(a) of the Credit Agreement is hereby amended by adding at the end of the first
sentence therein the following proviso: 
  
 “; provided further, however, that until the Restatement Conditions have been satisfied, as confirmed by certificates from the Borrower to the Administrative Agent reasonably satisfactory to the Administrative
Agent, the Borrower agrees that the Revolving Credit A Outstandings shall not exceed $63,580,000 on or after the Amendment No. 8 Effective Date without the prior written consent of the Required Lenders and the Required Revolving Credit A
Lenders” 
  
 SECTION 3. Conditions to Effectiveness.
This Waiver and Amendment shall become effective as of the date first above written (the “Effective Date”), and shall continue to be effective so long as the Waiver Termination Date shall not have occurred, when: 
  
 (a) the Administrative Agent shall have received
counterparts of this Waiver and Amendment executed by the Borrower, the Required Lenders and the Required Revolving Credit A Lenders or, as to any of the Lenders, advice satisfactory to the Administrative Agent that such Lender has executed this
Waiver and Amendment, 
  
 (b) payment in full of
all expenses of the Administrative Agent related to this Waiver and Amendment (including all outstanding legal fees of counsel to the Administrative Agent incurred in connection with the Credit Agreement since the last date of payment of such fees)
shall have been by the Borrower, and 
  
 (c) the
Administrative Agent shall have received the consent attached hereto executed by each Guarantor. 
  
 This Waiver and Amendment is subject to the provisions of Section 10.01 of the Credit Agreement. 
  
 Notwithstanding the foregoing, it is understood and agreed that, upon the
occurrence of the Waiver Termination Date, the Administrative Agent and the Lenders shall have all of the rights and remedies afforded to them under the Credit Agreement with respect to any Defaults and Events of Default resulting from the
ineffectiveness of such amendments as though no amendments had been granted by them hereunder. 
  
 SECTION 4. Covenant to Deliver Account Control Agreements. The parties hereto agree that, pursuant to Section 5 of the Security Agreement, the Loan Parties shall deliver to the Administrative Agent, within 30
days after the Effective Date (which time period may be extended by up to an additional 60 days at the sole discretion of the Administrative Agent), Account Control Agreements (as defined in the Security Agreement) or such other “control
agreements” in form and substance satisfactory to the Administrative Agent and covering such of the Loan Parties’ Account Collateral as may be required by the Administrative Agent in its sole discretion. 
  
 SECTION 5. No Default; Representations and Warranties. To induce the
Lenders and the Administrative Agent to enter into this Waiver and Amendment, each Loan Party hereby represents and warrants to the Lenders and the Administrative Agent that after giving effect to this Waiver and Amendment, (a) except as set forth
herein, no Default or Event of Default has occurred and is continuing as of the date hereof and (b) except as set forth herein, the representations and warranties contained in the Credit Agreement and the other Loan 
  
 NDCHealth Corporation – Waiver and Amendment 
  

 5 

 Documents are true and correct in all material respects, except (x) to the extent that such representations and
warranties specifically refer to an earlier date, in which case they shall be true and correct in all material respects as of such earlier date and (y) for the representations and warranties set forth in Sections 5.05(b) and (c) and in Section 5.15
of the Credit Agreement with respect to the Restated Financial Statements that are waived hereunder. Notwithstanding the foregoing, the Borrower represents and warrants that after the Restatement the Borrower will be in compliance with the financial
covenants set forth in Section 7.11 of the Credit Agreement for the first quarter of Fiscal Year 2003 through the first quarter of the Fiscal Year 2005. 
  
 SECTION 6. Reference to and Effect on the Loan Documents. This Waiver and Amendment constitutes a Loan Document. The Credit Agreement, the Notes
and each of the other Loan Documents, except to the extent of the waiver and amendments specifically provided above, are and shall continue to be in full force and effect and are hereby in all respects ratified and confirmed. Without limiting the
generality of the foregoing, the Collateral Documents and all of the Collateral described therein do and shall continue to secure the payment of all Obligations of the Loan Parties under the Loan Documents. The execution, delivery and effectiveness
of this Waiver and Amendment shall not, except as expressly provided herein, operate as a waiver of any right, power or remedy of any Lender or the Administrative Agent under the Credit Agreement, nor constitute a waiver of any provision of the
Credit Agreement. The Waiver set forth in Section 1 hereof shall be limited precisely as written and shall not be deemed or otherwise construed to constitute a waiver of any variation from the Credit Agreement or to waive any Default or Event of
Default that has occurred or may in the future occur under the Credit Agreement, except as expressly set forth herein. 
  
 On and after and during the effectiveness of this Waiver and Amendment, each reference in the Credit Agreement to “this Agreement”,
“hereunder”, “hereof” or words of like import referring to the Credit Agreement, and each reference in the Notes and each of the other Loan Documents to “the Credit Agreement”, “thereunder”,
“thereof” or words of like import referring to the Credit Agreement, shall mean and be a reference to the Credit Agreement, as amended by this Waiver and Amendment. 
  
 If you agree to the terms and provisions of this Waiver and Amendment, please evidence such agreement by executing and
returning at least four counterparts of this Waiver and Amendment to Shearman & Sterling LLP, 599 Lexington Avenue, New York, New York 10022, Attention: Catherine Cataño, Fax No. 646-848-4861. 
  
 This Waiver and Amendment may be executed in any number of counterparts and
by different parties hereto in separate counterparts, each of which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same agreement. Delivery of an executed counterpart of a signature
page to this Waiver and Amendment by telecopier shall be effective as delivery of a manually executed counterpart of this Waiver and Amendment. 
  
 NDCHealth Corporation – Waiver and Amendment 
  

 6 

 This Waiver and Amendment shall be governed by, and construed in accordance with, the laws of the State
of New York. 
  

			
	Very truly yours,
	
	NDCHEALTH CORPORATION
		
	By	 	 /s/    LEE ADREAN

	Title:	 	CFO

  
 NDCHealth
Corporation – Waiver and Amendment 

 Agreed as of the date first above written: 
  
 MERRILL LYNCH CAPITAL, a division 
 of Merrill Lynch Business Financial Services Inc., 
 as Administrative Agent,
as Swing Line Lender 
 and as Lender 
  

			
	By	 	 [SIGNATURE TO COME]

	 	 	 Troy A. Oder

	Title:	 	 Vice President

  
 NDCHealth Corporation
– Waiver and Amendment 

			
	BANK OF AMERICA, N.A.
		
	By	 	 [SIGNATURE TO COME]

	Title:	 	Senior Vice President

  
 NDCHealth Corporation
– Waiver and Amendment 

 BlackRock Senior Loan Trust 
 Magnetite Asset Investors LLC 
 Magnetite IV CLO, Limited 
 Magnetite V CLO, Limited 
 Senior Loan Fund 
  

			
	By	 	 [SIGNATURE TO COME]

	Title:	 	Authorized Signatory

 CREDIT SUISSE FIRST BOSTON, acting through its Cayman Islands Branch 
  

			
	 By
	 	 [SIGNATURE TO COME]

	 	 	 Paul L. Colón

	 Title:
	 	 Director

		
	 By
	 	 [SIGNATURE TO COME]

	 	 	 Karim Blasetti

	 Title:
	 	 Associate

  
 NDCHealth Corporation
– Waiver and Amendment 

 Denali Capital LLC, managing member of DC 
 Funding Partners, portfolio manager for DENALI 
 CAPITAL CLO I, LTD., or an affiliate 
  

			
	 By
	 	 [SIGNATURE TO COME]

	 	 	 David A. Tanny

	 Title:
	 	 Vice President

  
 NDCHealth Corporation
– Waiver and Amendment 

 Denali Capital LLC, managing member of 
 DC Funding Partners, portfolio manager for 
 DENALI CAPITAL CLO II, LTD., or an affiliate 
  

			
	 By
	 	 [SIGNATURE TO COME]

	 	 	 David A. Tanny

	 Title:
	 	 Vice President

  
 NDCHealth Corporation
– Waiver and Amendment 

			
	 Denali Capital LLC, managing member of
 DC
Funding Partners, portfolio manager for
 DENALI CAPITAL CLO III, LTD., or an affiliate

		
	By	 	 [SIGNATURE TO COME]

	 	 	David A. Tanny
	Title:	 	Vice President

  
 NDCHealth Corporation
– Waiver and Amendment 

			
	 Flagship CLO II
 by Flagship Capital
Management, Inc.

		
	By:	 	 [SIGNATURE TO COME]

	Name:	 	Eric S. Meyer
	Title:	 	Director

  
 NDCHealth Corporation
– Waiver and Amendment 

			
	 Flagship CLO 2001-1
 by Flagship Capital
Management, Inc.
  

	 By:
	 	 [SIGNATURE TO COME]

	 Name:
	 	 Eric S. Meyer

	 Title:
	 	 Director

  
 NDCHealth Corporation
– Waiver and Amendment 

 GENERAL ELECTRIC CAPITAL CORPORATION 
  

			
	 By
	 	 [SIGNATURE TO COME]

	 	 	 Steve J. Warner

	 Title:
	 	 Duly Authorized Signatory

  
 NDCHealth Corporation
– Waiver and Amendment 

			
	 ING CAPITAL LLC

		
	 By
	 	 [SIGNATURE TO COME]

	 Name:
	 	 Michael P. Garvin, Jr.

	 Title:
	 	 Director

  
 NDCHealth Corporation
– Waiver and Amendment 

 KEY CORPORATE CAPITAL INC. 
  

			
	 By
	 	 [SIGNATURE TO COME]

	 Title:
	 	 Senior Vice President

  
 NDCHealth Corporation
– Waiver and Amendment 

			
	KEYBANK NATIONAL ASSOCIATION,
		
	By	 	 [SIGNATURE TO COME]

	Title:	 	Senior Vice President

  
 NDCHealth Corporation
– Waiver and Amendment 

			
	 LaSalle Bank National Association

		
	 By
	 	 [SIGNATURE TO COME]

	 Title:
	 	 Vice President

  
 NDCHealth Corporation
– Waiver and Amendment 

			
	 Regions Bank
  

	 By
	 	 [SIGNATURE TO COME]

	 Title:
	 	 Senior Vice President

  
 NDCHealth Corporation
– Waiver and Amendment 

 Venture CDO 2002, Limited 
  
 By its investment advisor, MJX Asset Management LLC 
  

			
	 By
	 	 [SIGNATURE TO COME]

	 	 	 Kenneth Ostmann

	 Title:
	 	 Director

			
	Venture II CDO 2002, Limited
	
	By its investment advisor, MJX Asset Management LLC
		
	By	 	 [SIGNATURE TO COME]

	 	 	Kenneth Ostmann
	Title:	 	Director

 CONSENT 
  
 Dated as of March 16, 2005 
  
 Each of the undersigned, as Guarantor under the Guaranty dated November 26, 2002 (the “Guaranty”) in favor of the Administrative Agent
and, for its benefit and the benefit of the Lenders parties to the Credit Agreement referred to in the foregoing Waiver and Amendment, hereby consents to such Waiver and Amendment and hereby confirms and agrees that (a) notwithstanding the
effectiveness of such Waiver and Amendment, the Guaranty is, and shall continue to be, in full force and effect and is hereby ratified and confirmed in all respects, and (b) the Collateral Documents to which each of the undersigned is a party and
all of the Collateral described therein do, and shall continue to, secure the payment of all of the Secured Obligations (in each case, as defined therein), except that, on and after the effectiveness of such Waiver and Amendment, each reference in
the Guaranty and the Collateral Documents to the “Credit Agreement”, “thereunder”, “thereof” or words of like import shall mean and be a reference to the Credit Agreement, as amended by such Waiver and Amendment.

  

			
	 NDC HEALTH INFORMATION SERVICES
 (ARIZONA)
INC.

		
	By	 	 /s/    LEE ADREAN

	Title:	 	EVP
	
	NDC OF CANADA, INC.
		
	By	 	 /s/    LEE ADREAN

	Title:	 	EVP

  
 NDCHealth
Corporation – Waiver and AmendmentIndemnity Agreement between the Company and Steve Robinson

 EXHIBIT 10.29 
  
 INDEMNITY AGREEMENT 
  
 This Agreement is made as of May 13, 2005, by and between Merix Corporation, an Oregon corporation (the “Corporation”), and Steven Robinson
(“Indemnitee”), a director and/or officer of the Corporation. 
  
 WHEREAS, it is essential to the Corporation to retain and attract as directors and officers of the Corporation and its subsidiaries the most capable persons available; and 
  
 WHEREAS, corporate litigation subjects directors and officers to expensive litigation risks at the same time that adequate
coverage of directors’ and officers’ liability insurance may be unavailable; and 
  
 WHEREAS, the Articles of Incorporation of the Corporation require indemnification of the officers and directors of the Corporation to the fullest extent permitted by law. The Articles and the Oregon Business
Corporation Act (the “Act”) expressly provide that the indemnification provisions set forth in the Act are not exclusive, and thereby contemplate that contracts may be entered into between the Corporation and members of the Board of
Directors and officers with respect to indemnification of directors and officers; and 
  
 WHEREAS, Indemnitee does not regard the protection available under the Corporation’s Articles of Incorporation, Bylaws and insurance adequate in the present circumstances, and may not be willing to serve as a
director or officer without adequate protection, and the Corporation desires Indemnitee to serve in such capacity. 
  
 NOW THEREFORE, the Corporation and Indemnitee agree as follows: 
  

	1.	Agreement to Serve. Indemnitee agrees to serve or continue to serve as a director and/or officer of the Corporation and/or one or more of its subsidiaries for so long as
Indemnitee is duly elected or appointed or until such time as Indemnitee tenders a resignation in writing. 

  

	2.	Definitions. As used in this Agreement: 

  

	(a)	The term “Proceeding” shall include any threatened, pending or completed action, suit or proceeding, whether brought in the right of the Corporation or otherwise, whether
of a civil, criminal, administrative or investigative nature, and whether formal or informal, in which Indemnitee may be or may have been involved as a party or otherwise, by reason of the fact that Indemnitee is or was a director and/or officer of
the Corporation, or is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, whether or not serving in such capacity at the time any
liability or expense is incurred for which indemnification or reimbursement can be provided under this Agreement. 

  

	(b)	The term “Expenses” includes, without limitation thereto, expense of investigations, judicial or administrative proceedings or appeals, amounts paid in settlement by
Indemnitee, attorneys’ fees and disbursements and any expenses of establishing a right to indemnification under Section 7 of this Agreement, but shall not include the amount of judgments or fines against Indemnitee.

  

	(c)	References to “other enterprises” shall include employee benefit plans; references to “fines” shall include any excise tax assessed with respect to any employee
benefit plan; references to “serving at the request of the corporation” shall include any service as a director, officer, employee or agent of the Corporation which imposes duties on, or involves services by, such director, officer,
employee or agent with respect to an employee benefit plan, its participants, or beneficiaries; and a person who acted in good faith and in a manner reasonably believed to be in the interest of an employee benefit plan shall be deemed to have acted
in a manner “not opposed to the best interests of the Corporation” as referred to in this Agreement. 

  

	3.	 Indemnity in Third Party Proceedings. The Corporation shall indemnify Indemnitee in accordance with the provisions of this Section 3 if Indemnitee is a
party to or threatened to be made a party to any Proceeding (other than a Proceeding by or in the right of the Corporation to procure a judgment in its favor) against all Expenses, judgments and fines actually and reasonably incurred by Indemnitee
in connection with such Proceeding, but only if Indemnitee acted in 

	 	 
good faith and in a manner which Indemnitee reasonably believed to be in or not opposed to the best interests of the Corporation and, in the case of a
criminal proceeding, in addition, had no reasonable cause to believe that Indemnitee’s conduct was unlawful. The termination of any such Proceeding by judgment, order of court, settlement, conviction or upon a plea of nolo contendere, or its
equivalent, shall not, of itself, create a presumption that Indemnitee did not act in good faith and in a manner which Indemnitee reasonably believed to be in the best interest of the Corporation, and with respect to any criminal proceeding, that
such person had reasonable cause to believe that Indemnitee’s conduct was unlawful. 

  
 Pursuant to this Agreement, the Corporation specifically will, and hereby does, indemnify, to the fullest extent permitted by law, Indemnitee against any
and all losses, claims, damages, liabilities and expenses, joint or several, (or actions or proceedings, whether commenced or threatened, in respect thereof) to which Indemnitee may become subject, as a result of serving as a director and/or officer
of Merix, under the Securities Act or any other statute or common law, including any amount paid in settlement of any litigation, commenced or threatened, and to reimburse them for any legal or other expenses incurred by them in connection with
investigating any claims and defending any actions, insofar as any such losses, claims, damages, liabilities, expenses or actions arise out of or are based upon any untrue statement or alleged untrue statement of a material fact regarding Merix, or
the omission or alleged omission to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. 
  

	4.	Indemnity in Proceedings by or in the Right of the Corporation. The Corporation shall indemnify Indemnitee in accordance with the provisions of this Section 4 if
Indemnitee is a party to or threatened to be made a party to any Proceeding by or in the right of the Corporation to procure a judgment in its favor against all Expenses actually and reasonably incurred by Indemnitee in connection with the defense
or settlement of such Proceeding, but only if Indemnitee acted in good faith and in a manner which Indemnitee reasonably believed to be in or not opposed to the best interests of the Corporation, except that no indemnification for Expenses shall be
made under this Section 4 in respect of any claim, issue or matter as to which such person shall have been finally adjudged by a court to be liable for negligence or misconduct in the performance of Indemnitee’s duty to the Corporation,
unless and only to the extent that any court in which such Proceeding was brought shall determine upon application that, despite the adjudication of liability but in view of all the circumstances of the case, Indemnitee is fairly and reasonably
entitled to indemnity. 

  

	5.	Indemnification of Expenses of Successful Party. Notwithstanding any other provisions of this Agreement, to the extent that Indemnitee has been successful on the merits or
otherwise, in defense of any Proceeding or in defense of any claim, issue or matter therein, including the dismissal of an action without prejudice, Indemnitee shall be indemnified against all Expenses incurred in connection therewith.

  

	6.	Advances of Expenses. The Expenses incurred by Indemnitee pursuant to Sections 3, 4 and 8 in any Proceeding shall be paid by the Corporation in advance at the written request
of Indemnitee, if Indemnitee shall undertake to repay such amount to the extent that it is ultimately determined by a court that Indemnitee is not entitled to be indemnified by the Corporation and shall furnish the Corporation a written affirmation
of the Indemnitee’s good faith belief that Indemnitee is entitled to be indemnified by the Corporation under this Agreement. Such advances shall be made without regard to Indemnitee’s ability to repay such expenses.

  

	7.	Right of Indemnitee to Indemnification Upon Application; Procedure Upon Application. Any indemnification or advances under Sections 3, 4, 6 or 8 shall be made no later than
45 days after receipt of the written request of Indemnitee, unless a determination is made within such 45 day period by (a) the Board of Directors by a majority vote of a quorum consisting of directors who were not parties to such proceeding,
or (b) independent legal counsel in a written opinion (which counsel shall be appointed if such quorum is not obtainable), that the Indemnitee has not met the relevant standards for indemnification set forth in Section 3, 4 or 8 or an
exclusion set forth in Section 9 is applicable. 

  
 The right to indemnification or advances as provided by this Agreement shall be enforceable by Indemnitee in any court of competent jurisdiction. The burden of proving that indemnification or advances are not appropriate shall be on the
Corporation. Neither the failure of the Corporation (including its Board of Directors or independent legal counsel) to have made a determination prior to the commencement of such action that indemnification or advances are proper in the
circumstances because Indemnitee has met the applicable standard of conduct nor an actual determination by the Corporation (including its Board of Directors or independent legal counsel) that Indemnitee has not met such applicable standard of
conduct, shall be a defense to the action or create a presumption that Indemnitee has not met the applicable 
  

 1 

	 	 
standard of conduct. Indemnitee’s expenses incurred in connection with successfully establishing Indemnitee’s right to indemnification or advances,
in whole or in part, in any such Proceeding shall also be indemnified by the Corporation. 

  

	8.	Additional Indemnification. 

  

	(a)	Notwithstanding any limitation in Sections 3 or 4, the Corporation shall indemnify Indemnitee in accordance with the provisions of this Section 8(a) to the fullest extent
permitted by law if Indemnitee is party to or threatened to be made a party to any Proceeding (including a Proceeding by or in the right of the Corporation to procure a judgment in its favor) involving a claim against Indemnitee for breach of
fiduciary duty by Indemnitee against all Expenses, judgments and fines actually and reasonably incurred by Indemnitee in connection with such Proceeding, provided that no indemnity shall be made under this Section 8(a) on account of
Indemnitee’s conduct which constitutes a breach of Indemnitee’s duty of loyalty to the Corporation or its stockholders or is an act or omission not in good faith or which involves intentional misconduct or a knowing violation of the law or
with respect to an unlawful distribution under ORS 60.367. 

  

	(b)	Notwithstanding any limitation in Sections 3, 4 or 8(a), the Corporation shall indemnify Indemnitee if Indemnitee is a party to or threatened to be made a party to any Proceeding
(including a Proceeding by or in the right of the Corporation to procure a judgment in its favor) against all Expenses, judgments and fines actually and reasonably incurred by Indemnitee in connection with such Proceeding to the fullest extent
permitted by the Act, including the nonexclusivity provision of ORS 60.414(1) and any successor provision and including any amendments to the Act adopted after the date hereof that may increase the extent to which a corporation may indemnify its
officers and directors. 

  

	(c)	The indemnification provided by this Agreement shall not be deemed exclusive of any other rights to which Indemnitee may be entitled under the Restated Articles of Incorporation,
the Bylaws, any other agreement, any vote of shareholders or directors, the Act, or otherwise, both as to action in Indemnitee’s official capacity or as to action in another capacity while holding such office. The indemnification under this
Agreement shall continue as to Indemnitee even though Indemnitee may have ceased to be a director or officer and shall inure to the benefit of the heirs and personal representatives of Indemnitee. 

  

	9.	Exclusions. Notwithstanding any provision in this Agreement, the Corporation shall not be obligated under this Agreement to make any indemnification or advances in connection
with any claim made against Indemnitee: 

  

	(a)	for which payment is required to be made to or on behalf of Indemnitee under any insurance policy, except with respect to any excess beyond the amount of required payment under such
insurance, unless payment under such insurance policy is not made after reasonable effort by Indemnitee to obtain payment. The Corporation shall be subrogated with respect to any other rights of Indemnitee with respect to any payment made by the
Corporation to or on behalf of the Corporation under this Agreement; 

  

	(b)	for any transaction from which Indemnitee derived an improper personal benefit; or 

  

	(c)	for an accounting of profits made from the purchase and sale by Indemnitee of securities of the Corporation within the meaning of Section 16(b) of the Securities Exchange Act
of 1934 and amendments thereto or similar provisions of any state statutory law or common law. 

  

	10.	Partial Indemnification. If Indemnitee is entitled under any provisions of this Agreement to indemnification by the Corporation for some or a portion of the Expenses,
judgments and fines actually and reasonably incurred by Indemnitee in the investigation, defense, appeal or settlement of any Proceeding but not, however, for the total amount thereof, the Corporation shall nevertheless indemnify Indemnitee for the
portion of such Expenses, judgments or fines to which Indemnitee is entitled. 

  

	11.	Business Transactions. The Corporation agrees that it will not effect any Business Transaction (as defined in Article XI of the Restated Articles of Incorporation of the
Corporation) which has not been approved by the Continuing Directors (as defined in Article XI of the Restated Articles of Incorporation of the Corporation) of the Corporation unless the other party to the transaction agrees in writing to
(a) use its best efforts to maintain for the subsequent two year period any and all directors’ and officers’ liability insurance in effect prior to any discussions or announcement relating to such Business Transaction and
(b) assume all obligations of the Corporation under this Agreement and indemnify Indemnitee and advance litigation expenses in accordance with this Agreement. 

  

 2 

	12.	Severability. If this Agreement or any portion thereof shall be invalidated on any ground by any court of competent jurisdiction, then the Corporation shall nevertheless
indemnify Indemnitee as to Expenses, judgments and fines with respect to any Proceeding to the full extent permitted by any applicable portion of this Agreement that shall not have been invalidated or by any other applicable law.

  

	13.	Notice. Indemnitee shall, as a condition precedent to Indemnitee’s right to be indemnified under this Agreement, give to the Corporation notice in writing as soon as
practicable of any claim made against Indemnitee for which indemnity will or could be sought under this Agreement. Notice to the Corporation shall be directed to Merix Corporation, 1521 Poplar Lane, Forest Grove, Oregon 97116, Attention: Secretary
(or such other address as the Corporation shall designate in writing to Indemnitee). Notice shall be deemed received three days after the date postmarked if sent by prepaid mail, properly addressed. In addition, Indemnitee shall give the Corporation
such information and cooperation as it may reasonably require and as shall be within Indemnitee’s power. 

  

	14.	Counterparts. This Agreement may be executed in any number of counterparts, each of which shall constitute the original. 

  

	15.	Applicable Law. This Agreement shall be governed by and construed in accordance with Oregon law. 

  

	16.	Successors and Assigns. This Agreement shall be binding upon the Corporation and its successors and assigns. 

 IN WITNESS WHEREOF, the parties hereby have caused this Agreement to be duly executed and signed as of the day and year first above written. 
  

			
	MERIX CORPORATION
		
	By:	 	 /s/ Mark R. Hollinger

	 	 	 Mark R. Hollinger
 Chairman, Chief Executive Officer and President

	
	 INDEMNITEE

	
	 /s/Steven Robinson

  

 3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00089-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00089-of-00352.parquet"}]]